Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE18.9300
- TODAY'S CHANGE (%)-1.9800 (-9.4692%)
- Bid / Lots17.8600/ 1
- Ask / Lots19.7400/ 1
- Open / Previous Close20.8000 / 20.9100
- Day Range
- 52 Week Range
- Volume868,306
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 7224 | 20.64 |
| 09:34 ET | 592 | 20.755 |
| 09:36 ET | 750 | 20.43 |
| 09:38 ET | 419 | 20.33 |
| 09:39 ET | 1200 | 20.52 |
| 09:41 ET | 625 | 20.595 |
| 09:43 ET | 400 | 20.61 |
| 09:45 ET | 30251 | 20.75 |
| 09:50 ET | 300 | 20.715 |
| 09:52 ET | 4884 | 20.67 |
| 09:54 ET | 200 | 20.63 |
| 09:56 ET | 500 | 20.6733 |
| 09:57 ET | 300 | 20.69 |
| 09:59 ET | 1797 | 20.665 |
| 10:01 ET | 1217 | 20.74 |
| 10:03 ET | 812 | 20.6 |
| 10:06 ET | 1153 | 20.5301 |
| 10:08 ET | 3189 | 20.575 |
| 10:10 ET | 700 | 20.725 |
| 10:12 ET | 900 | 20.77 |
| 10:14 ET | 1100 | 20.785 |
| 10:15 ET | 743 | 20.785 |
| 10:17 ET | 1800 | 20.9 |
| 10:19 ET | 100 | 20.8715 |
| 10:21 ET | 400 | 20.905 |
| 10:24 ET | 9461 | 20.9 |
| 10:26 ET | 300 | 20.94 |
| 10:28 ET | 300 | 20.815 |
| 10:30 ET | 100 | 20.7 |
| 10:32 ET | 300 | 20.83 |
| 10:33 ET | 200 | 20.77 |
| 10:35 ET | 400 | 20.8 |
| 10:37 ET | 800 | 20.8 |
| 10:39 ET | 700 | 20.65 |
| 10:42 ET | 682 | 20.745 |
| 10:44 ET | 100 | 20.74 |
| 10:46 ET | 400 | 20.52 |
| 10:48 ET | 200 | 20.54 |
| 10:50 ET | 200 | 20.54 |
| 10:51 ET | 200 | 20.565 |
| 10:53 ET | 300 | 20.58 |
| 10:55 ET | 600 | 20.57 |
| 10:57 ET | 1455 | 20.545 |
| 11:00 ET | 100 | 20.53 |
| 11:02 ET | 700 | 20.59 |
| 11:04 ET | 2198 | 20.6 |
| 11:06 ET | 4928 | 20.6567 |
| 11:08 ET | 2083 | 20.5201 |
| 11:09 ET | 300 | 20.535 |
| 11:11 ET | 1350 | 20.61 |
| 11:13 ET | 1401 | 20.71 |
| 11:15 ET | 3885 | 20.855 |
| 11:18 ET | 1124 | 20.85 |
| 11:20 ET | 520 | 20.805 |
| 11:22 ET | 4100 | 20.84 |
| 11:24 ET | 400 | 20.82 |
| 11:26 ET | 900 | 20.82 |
| 11:27 ET | 200 | 20.825 |
| 11:29 ET | 2045 | 20.87 |
| 11:31 ET | 1332 | 20.9 |
| 11:33 ET | 877 | 20.885 |
| 11:36 ET | 1300 | 20.84 |
| 11:38 ET | 2283 | 20.865 |
| 11:40 ET | 3060 | 20.8 |
| 11:42 ET | 500 | 20.8 |
| 11:44 ET | 2754 | 20.81 |
| 11:45 ET | 980 | 20.82 |
| 11:47 ET | 600 | 20.815 |
| 11:49 ET | 1600 | 20.815 |
| 11:51 ET | 500 | 20.79 |
| 11:54 ET | 1100 | 20.79 |
| 11:56 ET | 791 | 20.79 |
| 11:58 ET | 1033 | 20.84 |
| 12:00 ET | 1356 | 20.79 |
| 12:02 ET | 29461 | 20.53 |
| 12:03 ET | 1150 | 20.51 |
| 12:05 ET | 900 | 20.495 |
| 12:07 ET | 200 | 20.52 |
| 12:09 ET | 1103 | 20.55 |
| 12:12 ET | 2238 | 20.62 |
| 12:16 ET | 45022 | 20.38 |
| 12:18 ET | 300 | 20.36 |
| 12:20 ET | 2000 | 20.3 |
| 12:21 ET | 200 | 20.31 |
| 12:23 ET | 3600 | 20.36 |
| 12:25 ET | 1100 | 20.35 |
| 12:27 ET | 825 | 20.28 |
| 12:30 ET | 3046 | 20.25 |
| 12:32 ET | 100 | 20.22 |
| 12:34 ET | 200 | 20.245 |
| 12:36 ET | 5547 | 19.995 |
| 12:38 ET | 945 | 20.055 |
| 12:39 ET | 600 | 20.1 |
| 12:41 ET | 1400 | 20.03 |
| 12:43 ET | 300 | 20.04 |
| 12:45 ET | 3289 | 19.92 |
| 12:48 ET | 3770 | 19.86 |
| 12:50 ET | 1001 | 19.89 |
| 12:52 ET | 100 | 19.9 |
| 12:54 ET | 921 | 19.86 |
| 12:56 ET | 326 | 19.85 |
| 12:57 ET | 300 | 19.79 |
| 12:59 ET | 8873 | 19.75 |
| 01:01 ET | 1300 | 19.72 |
| 01:03 ET | 3709 | 19.79 |
| 01:06 ET | 800 | 19.8026 |
| 01:08 ET | 200 | 19.79 |
| 01:10 ET | 1400 | 19.845 |
| 01:12 ET | 800 | 19.84 |
| 01:14 ET | 600 | 19.86 |
| 01:15 ET | 475 | 19.8355 |
| 01:17 ET | 738 | 19.89 |
| 01:19 ET | 3711 | 19.85 |
| 01:21 ET | 919 | 19.8 |
| 01:24 ET | 200 | 19.775 |
| 01:26 ET | 302 | 19.74 |
| 01:28 ET | 100 | 19.7 |
| 01:30 ET | 1925 | 19.73 |
| 01:32 ET | 420 | 19.72 |
| 01:33 ET | 1900 | 19.7627 |
| 01:35 ET | 2920 | 19.7 |
| 01:37 ET | 947 | 19.75 |
| 01:39 ET | 673 | 19.74 |
| 01:42 ET | 3832 | 19.55 |
| 01:44 ET | 602 | 19.54 |
| 01:46 ET | 4700 | 19.58 |
| 01:48 ET | 100 | 19.56 |
| 01:50 ET | 460 | 19.5609 |
| 01:51 ET | 782 | 19.58 |
| 01:53 ET | 200 | 19.58 |
| 01:55 ET | 1100 | 19.62 |
| 01:57 ET | 800 | 19.58 |
| 02:00 ET | 1600 | 19.54 |
| 02:02 ET | 2784 | 19.48 |
| 02:04 ET | 4327 | 19.52 |
| 02:06 ET | 400 | 19.55 |
| 02:08 ET | 1300 | 19.53 |
| 02:09 ET | 100 | 19.55 |
| 02:11 ET | 200 | 19.53 |
| 02:13 ET | 706 | 19.49 |
| 02:15 ET | 1572 | 19.5 |
| 02:18 ET | 585 | 19.4725 |
| 02:20 ET | 200 | 19.45 |
| 02:22 ET | 400 | 19.45 |
| 02:24 ET | 300 | 19.48 |
| 02:26 ET | 4200 | 19.47 |
| 02:27 ET | 550 | 19.495 |
| 02:29 ET | 1700 | 19.51 |
| 02:31 ET | 875 | 19.49 |
| 02:33 ET | 1503 | 19.5 |
| 02:36 ET | 1000 | 19.55 |
| 02:38 ET | 600 | 19.56 |
| 02:40 ET | 3650 | 19.54 |
| 02:42 ET | 2842 | 19.5 |
| 02:44 ET | 100 | 19.43 |
| 02:45 ET | 1974 | 19.38 |
| 02:47 ET | 1041 | 19.36 |
| 02:49 ET | 1691 | 19.28 |
| 02:51 ET | 1050 | 19.3 |
| 02:54 ET | 3593 | 19.2501 |
| 02:56 ET | 11121 | 19.25 |
| 02:58 ET | 1400 | 19.25 |
| 03:00 ET | 1673 | 19.2 |
| 03:02 ET | 530 | 19.22 |
| 03:03 ET | 400 | 19.23 |
| 03:05 ET | 751 | 19.2 |
| 03:07 ET | 1400 | 19.21 |
| 03:09 ET | 600 | 19.2 |
| 03:12 ET | 2198 | 19.19 |
| 03:14 ET | 520 | 19.12 |
| 03:16 ET | 551 | 19.16 |
| 03:18 ET | 1200 | 19.25 |
| 03:20 ET | 4139 | 19.22 |
| 03:21 ET | 200 | 19.22 |
| 03:23 ET | 500 | 19.23 |
| 03:25 ET | 500 | 19.2 |
| 03:27 ET | 1227 | 19.24 |
| 03:30 ET | 3789 | 19.23 |
| 03:32 ET | 500 | 19.17 |
| 03:34 ET | 1250 | 19.11 |
| 03:36 ET | 2479 | 19.12 |
| 03:38 ET | 1161 | 19.13 |
| 03:39 ET | 2047 | 19.1 |
| 03:41 ET | 3558 | 19.045 |
| 03:43 ET | 4615 | 19.015 |
| 03:45 ET | 3167 | 19.075 |
| 03:48 ET | 4626 | 18.97 |
| 03:50 ET | 3588 | 18.931 |
| 03:52 ET | 3813 | 18.995 |
| 03:54 ET | 3576 | 19.01 |
| 03:56 ET | 46949 | 18.91 |
| 03:57 ET | 11726 | 18.87 |
| 03:59 ET | 54174 | 18.93 |
Jun 27, 2024
DJ Nurix Therapeutics Is Maintained at Outperform by RBC Capital, from 10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 18, 2024
DJ Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 17, 2024
DJ Nurix Therapeutics Is Maintained at Overweight by JP Morgan, from 10:19AM ET on Monday Jun 17, 2024 by Dow Jones
10:19AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Shares Rise on Positive Leukemia Drug Results, from 6:23AM ET on Monday Jun 17, 2024 by Dow Jones
6:23AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Price Target Maintained With a $31.00/Share by Needham, from 5:59AM ET on Monday Jun 17, 2024 by Dow Jones
5:59AM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.2B | -7.1x | --- |
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Immatics NV | 1.2B | -11.5x | --- |
Prothena Corporation PLC | 1.1B | -6.3x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.2x | --- |
Silence Therapeutics PLC | 874.4M | -15.5x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.22 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -7.1x |
Price/Sales (TTM) | 15.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
